164 results on '"Dieter P. Reinhardt"'
Search Results
152. Initial mechanisms in fibrillin_1 assembly
- Author
-
Ehab I. El-Hallous, Anthony S. Weiss, Takako Sasaki, Dirk Hubmacher, Dieter P. Reinhardt, E. C. Davis, and Kerstin Tiedemann
- Subjects
Chemistry ,Molecular Biology ,Fibrillin ,Cell biology - Published
- 2006
- Full Text
- View/download PDF
153. Contents Vol. 102, 2006
- Author
-
Yiming Wang, Markus Porst, Akio Koyama, Dieter P. Reinhardt, Catherine Alexakis, Andrea Hartner, Jingbo Zhang, Christian Plank, Joichi Usui, George Bou-Gharios, Yan Tang, Lijuan Chen, Tingting Zhao, Martin A. Turman, Yongwen Chen, Yuzhang Wu, Dorit Elberg, Karl Muffly, Risa Yamada, Charlotte J. Logan, Katsuyoshi Kanemoto, Gerard Elberg, Patrick H. Maxwell, Eduardo H. Garin, Liyun Zou, Jingyi Li, Christoph Daniel, Harald O. Schöcklmann, Michio Nagata, and Paul F. Laflam
- Subjects
Nephrology ,Physiology ,Genetics ,General Medicine - Published
- 2006
- Full Text
- View/download PDF
154. Subject Index Vol. 102, 2006
- Author
-
Jingyi Li, Yongwen Chen, Gerard Elberg, Patrick H. Maxwell, Christoph Daniel, Yuzhang Wu, Liyun Zou, Lijuan Chen, Katsuyoshi Kanemoto, Yiming Wang, Martin A. Turman, Eduardo H. Garin, Dieter P. Reinhardt, Andrea Hartner, Christian Plank, Catherine Alexakis, Joichi Usui, Markus Porst, Jingbo Zhang, Paul F. Laflam, Akio Koyama, George Bou-Gharios, Dorit Elberg, Karl Muffly, Risa Yamada, Charlotte J. Logan, Harald O. Schöcklmann, Michio Nagata, Yan Tang, and Tingting Zhao
- Subjects
Index (economics) ,Nephrology ,Physiology ,Statistics ,Genetics ,Subject (documents) ,General Medicine ,Mathematics - Published
- 2006
- Full Text
- View/download PDF
155. [Untitled]
- Author
-
Thomas Krieg, Nico Hunzelmann, Dieter P. Reinhardt, Lynn Y. Sakai, Jürgen Brinckmann, Ehab I. El-Hallous, and Sven Krengel
- Subjects
Pathology ,medicine.medical_specialty ,integumentary system ,Immunology ,Autoantibody ,macromolecular substances ,Biology ,medicine.disease ,Scleroderma ,law.invention ,Pathogenesis ,Mixed connective tissue disease ,Immune system ,Rheumatology ,law ,medicine ,biology.protein ,Recombinant DNA ,Immunology and Allergy ,Antibody ,skin and connective tissue diseases ,Fibrillin - Abstract
Autoantibodies against short recombinant fragments of fibrillin-1 produced in bacterial expression systems have been found in tight-skin mouse, systemic sclerosis, mixed connective tissue disease, and primary pulmonary hypertension syndrome. In patients with scleroderma, the frequency of anti-fibrillin-1 antibodies was 42% in Caucasians. Until now it has been unclear whether this immune response has a primary function in disease pathogenesis or is a secondary phenomenon. In the present study we analyzed the frequency of autoantibodies against two overlapping recombinant polypeptides spanning the N-terminal and C-terminal halves of human fibrillin-1, which were produced in human embryonic kidney (HEK-293) cells. Correct three-dimensional structures of the recombinant fibrillin-1 polypeptides were shown by electron microscopy and immunoreactivity with antibodies. Screening of fibrillin-1 antibodies was performed in 41 sera from systemic sclerosis patients and in 44 healthy controls with a Caucasian background. Microtiter plates were coated with the recombinant polypeptides of fibrillin-1 and incubated with 1:100 diluted sera. Positive binding was defined as being more than 2 SD above the mean of the control group. ELISAs showed that none of the sera of patients with systemic sclerosis contained autoantibodies against the N-terminal or C-terminal recombinant fibrillin-1 polypeptide. The data show the absence of autoantibodies against recombinant fibrillin-1 protein in Caucasian systemic sclerosis patients. Because the correct three-dimensional folding of the recombinant proteins has been substantiated by several independent methods, we conclude that autoantibodies against correctly folded fibrillin are not a primary phenomenon in the pathogenesis of systemic sclerosis.
- Published
- 2005
- Full Text
- View/download PDF
156. Corrigendum to 'Molecular Structure and Interaction of Recombinant Human Type XVI Collagen' [J. Mol. Biol. (2004) 339, 835–853]
- Author
-
Matthias Mörgelin, Susanne Grässel, Kerstin Tiedemann, Thomas Ludwig, Mon-Li Chu, Anja Kassner, Peter Bruckner, Holger Notbohm, and Dieter P. Reinhardt
- Subjects
Structural Biology ,Stereochemistry ,law ,Recombinant DNA ,Type XIX collagen ,Biology ,Human type ,Molecular Biology ,law.invention - Abstract
The authors would like to apologize for use of several instances, without acknowledgement, of words and ideas that had been published in the Discussion section of the paper “Type XIX Collagen Purified from Human Umbilical Cord is Characterized by Multiple Sharp Kinks Delineating Collagenous Subdomains and by Intermolecular Aggregates via Globular, Disulfide-linked, and Heparin-binding Amino Termini”, by Jeanne C. Myers, Deqin Li, Peter S. Amenta, Charles C. Clark, Chandrasekaran Nagaswami and John W. Weisel (J. Biol. Chem. 278, 32047–32057, 2003).”
- Published
- 2004
- Full Text
- View/download PDF
157. P4-345 LXR agonist treatment affects APP processing in brain of APP X PS2 double transgenic mice
- Author
-
Helmut Jacobsen, Denise Blum, Laurence Ozmen, Fabienne Goepfert, Hansruedi Loetscher, Patrick Biry, Matthew Wright, Markus Hänggi, Dieter P. Reinhardt, Dominik Hainzl, and Christian Czech
- Subjects
Agonist ,Genetically modified mouse ,Aging ,medicine.medical_specialty ,Chemistry ,medicine.drug_class ,General Neuroscience ,Endocrinology ,Internal medicine ,medicine ,Neurology (clinical) ,Geriatrics and Gerontology ,Liver X receptor ,Developmental Biology - Published
- 2004
- Full Text
- View/download PDF
158. A novel mutation of the fibrillin gene causing familial ectopia lentis with no cardiovascular manifestations
- Author
-
L. Lönnqvist, Lynn Y. Sakai, Dieter P. Reinhardt, K. kainulainen, Anne H. Child, Leena Peltonen, Leena Karttunen, and T. Rantamäki
- Subjects
Genetics ,business.industry ,Medicine ,business ,Molecular Biology ,Novel mutation ,Gene ,Fibrillin ,Familial ectopia lentis - Published
- 1994
- Full Text
- View/download PDF
159. Characterization of the renal phenotype in a mouse model of Marfan syndrome.
- Author
-
Andrea Hartner, Timo Eifert, Christian S. Haas, Cigdem Tuysuz, Karl F. Hilgers, Dieter P. Reinhardt, and Kerstin Amann
- Subjects
MARFAN syndrome ,PHENOTYPES ,KIDNEY glomerulus ,KIDNEYS ,HISTOLOGY - Abstract
The microfibrillar protein fibrillin-1 is expressed abundantly in the vasculature and the glomerulus of the kidney. Mutations in the fibrillin-1 gene lead to Marfan syndrome. The most common complication of this disease is aortic dilatation due to elastic deficiencies of the vascular wall. Several case reports describe glomerular disease in patients with Marfan syndrome, and fibrillin-1 has been implicated in nephrogenesis. To study the role of fibrillin-1 in renal development and function, we characterized the renal phenotype of fibrillin-1-underexpressing mice. Kidney histology was evaluated by means of morphometry and stereology. Relative kidney weights, daily urine excretion, urinary albumin excretion, serum and urinary creatinine, as well as serum urea were not different than wild-type mice. Glomerular number and renal capillarization were normal. The size of the renal filtration surface was comparable in wild-type and fibrillin-1-underexpressing mice. There was no indication for glomerular, renal vascular, or tubulointerstitial injury. However, glomerular volume and mesangial area were reduced. No changes in glomerular cell numbers were detected, but the cellular volume of mesangial cells was significantly lower in glomeruli of fibrillin-1-underexpressing mice. Thus, despite the high abundance of fibrillin-1 in glomeruli of wild-type animals, underexpression of fibrillin-1 did not lead to functional deficiencies of the glomerulus. Alterations in renal histology were only subtle with a reduced glomerular volume and mesangial area likely due to a reduced mesangial cell volume. [ABSTRACT FROM AUTHOR]
- Published
- 2004
160. Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly
- Author
-
B. Bätge, Kerstin Tiedemann, Dieter P. Reinhardt, and Peter K. Müller
- Subjects
musculoskeletal diseases ,Fibrillin-1 ,macromolecular substances ,Perlecan ,Fibrillins ,Biochemistry ,Dermatan sulfate ,chemistry.chemical_compound ,Sulfation ,Fibrillin Microfibrils ,medicine ,Chondroitin ,Humans ,skin and connective tissue diseases ,Molecular Biology ,DNA Primers ,Glycosaminoglycans ,integumentary system ,biology ,Base Sequence ,Heparin ,Microfilament Proteins ,Cell Biology ,Heparan sulfate ,Recombinant Proteins ,carbohydrates (lipids) ,chemistry ,biology.protein ,Heparitin Sulfate ,Fibrillin ,medicine.drug ,Protein Binding - Abstract
Fibrillin-1 is a major constituent of the 10-12 nm extracellular microfibrils. Here we identify, characterize, and localize heparin/heparan sulfate-binding sites in fibrillin-1 and report on the role of such glycosaminoglycans in the assembly of fibrillin-1. By using different binding assays, we localize two calcium-independent heparin-binding sites to the N-terminal (Arg(45)-Thr(450)) and C-terminal (Asp(1528)-Arg(2731)) domains of fibrillin-1. A calcium-dependent-binding site was localized to the central (Asp(1028)-Thr(1486)) region of fibrillin-1. Heparin binding to these sites can be inhibited by a highly sulfated and iduronated form of heparan sulfate but not by chondroitin 4-sulfate, chondroitin 6-sulfate, and dermatan sulfate, demonstrating that the heparin binding regions represent binding domains for heparan sulfate. When heparin or heparan sulfate was added to cultures of skin fibroblasts, the assembly of fibrillin-1 into a microfibrillar network was significantly reduced. Western blot analysis demonstrated that this effect was not due to a reduced amount of fibrillin-1 secreted into the culture medium. Inhibition of the attachment of glycosaminoglycans to core proteins of proteoglycans by beta-d-xylosides resulted in a significant reduction of the fibrillin-1 network. These studies suggest that binding of fibrillin-1 to proteoglycan-associated heparan sulfate chains is an important step in the assembly of microfibrils.
161. In vitro elastogenesis: instructing human vascular smooth muscle cells to generate an elastic fiber-containing extracellular matrix scaffold.
- Author
-
Svenja Hinderer, Nian Shen, Léa-Jeanne Ringuette, Jan Hansmann, Dieter P Reinhardt, Sara Y Brucker, Elaine C Davis, and Katja Schenke-Layland
- Published
- 2015
- Full Text
- View/download PDF
162. Fibrillin-1 Regulates Arteriole Integrity in the Retina
- Author
-
Florian Alonso, Ling Li, Isabelle Fremaux, Dieter Peter Reinhardt, and Elisabeth Génot
- Subjects
arterioles ,basement membrane ,endothelial cells ,fibrillin-1 ,Marfan syndrome ,MAGP1 ,Microbiology ,QR1-502 - Abstract
Fibrillin-1 is an extracellular matrix protein that assembles into microfibrils that provide critical functions in large blood vessels and other tissues. Mutations in the fibrillin-1 gene are associated with cardiovascular, ocular, and skeletal abnormalities in Marfan syndrome. Fibrillin-1 is a component of the wall of large arteries but has been poorly described in other vessels. We examined the microvasculature in the retina using wild type mice and two models of Marfan syndrome, Fbn1C1041G/+ and Fbn1mgR/mgR. In the mouse retina, fibrillin-1 was detected around arterioles, in close contact with the basement membrane, where it colocalized with MAGP1. Both a mutation in fibrillin-1 or fibrillin-1 underexpression characteristically altered the microvasculature. In Fbn1C1041G/+ and Fbn1mgR/mgR mice, arterioles were enlarged with reduced MAGP1 deposition and focal loss of smooth muscle cell coverage. Losartan, which prevents aortic enlargement in Fbn1C1041G/+ mice, prevented smooth muscle cell loss and vessel leakiness when administrated in a preventive mode. Moreover, losartan also partially rescued the defects in a curative mode. Thus, fibrillin-1/MAGP1 performs essential functions in arteriolar integrity and mutant fibrillin-1-induced defects can be prevented or partially rescued pharmacologically. These new findings could have implications for people with Marfan syndrome.
- Published
- 2022
- Full Text
- View/download PDF
163. Roles of fibronectin isoforms in neonatal vascular development and matrix integrity.
- Author
-
Heena Kumra, Laetitia Sabatier, Amani Hassan, Takao Sakai, Deane F Mosher, Jürgen Brinckmann, and Dieter P Reinhardt
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Fibronectin (FN) exists in two forms-plasma FN (pFN) and cellular FN (cFN). Although the role of FN in embryonic blood vessel development is well established, its function and the contribution of individual isoforms in early postnatal vascular development are poorly understood. Here, we employed a tamoxifen-dependent cFN inducible knockout (cFN iKO) mouse model to study the consequences of postnatal cFN deletion in smooth muscle cells (SMCs), the major cell type in the vascular wall. Deletion of cFN influences collagen deposition but does not affect life span. Unexpectedly, pFN translocated to the aortic wall in the cFN iKO and in control mice, possibly rescuing the loss of cFN. Postnatal pFN deletion did not show a histological aortic phenotype. Double knockout (dKO) mice lacking both, cFN in SMCs and pFN, resulted in postnatal lethality. These data demonstrate a safeguard role of pFN in vascular stability and the dispensability of the individual FN isoforms in postnatal vascular development. Complete absence of FNs in the dKOs resulted in a disorganized tunica media of the aortic wall. Matrix analysis revealed common and differential roles of the FN isoforms in guiding the assembly/deposition of elastogenic extracellular matrix (ECM) proteins in the aortic wall. In addition, we determined with two cell culture models that that the two FN isoforms acted similarly in supporting matrix formation with a greater contribution from cFN. Together, these data show that pFN exerts a critical role in safeguarding vascular organization and health, and that the two FN isoforms function in an overlapping as well as distinct manner to maintain postnatal vascular matrix integrity.
- Published
- 2018
- Full Text
- View/download PDF
164. Immobilized metal affinity chromatography co-purifies TGF-β1 with histidine-tagged recombinant extracellular proteins.
- Author
-
Jasvir Kaur and Dieter P Reinhardt
- Subjects
Medicine ,Science - Abstract
Extracellular recombinant proteins are commonly produced using HEK293 cells as histidine-tagged proteins facilitating purification by immobilized metal affinity chromatography (IMAC). Based on gel analyses, this one-step purification typically produces proteins of high purity. Here, we analyzed the presence of TGF-β1 in such IMAC purifications using recombinant extracellular fibrillin-1 fragments as examples. Analysis of various purified recombinant fibrillin-1 fragments by ELISA consistently revealed the presence of picomolar concentrations of active and latent TGF-β1, but not of BMP-2. These quantities of TGF-β1 were not detectable by Western blotting and mass spectrometry. However, the amounts of TGF-β1 were sufficient to consistently trigger Smad2 phosphorylation in fibroblasts. The purification mechanism was analyzed to determine whether the presence of TGF-β1 in these protein preparations represents a specific or non-specific co-purification of TGF-β1 with fibrillin-1 fragments. Control purifications using conditioned medium from non-transfected 293 cells yielded similar amounts of TGF-β1 after IMAC. IMAC of purified TGF-β1 and the latency associated peptide showed that these proteins bound to the immobilized nickel ions. These data clearly demonstrate that TGF-β1 was co-purified by specific interactions with nickel, and not by specific interactions with fibrillin-1 fragments. Among various chromatographic methods tested for their ability to eliminate TGF-β1 from fibrillin-1 preparations, gel filtration under high salt conditions was highly effective. As various recombinant extracellular proteins purified in this fashion are frequently used for experiments that can be influenced by the presence of TGF-β1, these findings have far-reaching implications for the required chromatographic schemes and quality controls.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.